Skip to content

Optimization of bicycle Ergometer training

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN44341748
Enrollment
340
Registered
2006-08-31
Start date
2005-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease Circulatory System Coronary heart disease

Interventions

Group one exercises with an intensity of 60% of the symptom-limited performance regulated by heart rate. Group two exercises metabolically regulated with an intenstity analogous to 60% of the intensit

Sponsors

Refonet (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Angiographic proved coronary disease 2. Echocardiogram (ECG) proved normal or slightly limited systolic cardiac function 3. Angina pectoris or acute coronary syndrome more than or equal to ten days before joining the research project 4. Sinus rhythm

Exclusion criteria

Exclusion criteria: 1. Acute coronary syndrome less than ten days before joining the research project 2. Moderate to severe limited sysolic cardiac function 3. Aorto-coronary bypass operation more than or equal to three months before joining the research project 4. Atrial fibrillations or therapy relevant ventricular arrythmia 5. Clinically limiting peripheral arterial disease 6. Present hypertrophic obstructive cardiac myopathy 7. Non-regulatable arterial hypertonia 8. Haemodynamically relevant cardiac valvular defect 9. Pericarditis, myocarditis and lung embolic more than or equal to six months before joining the research project 10. Limiting orthopaedic secondary disorders 11. Consuming and intercurrent diseases 12. Renal insufficiency (Creatinine > 2.0 mg/dl) 13. Anaemia (haemoglobin [Hb] < 12g/dl) 14. Severe chronic obstructive pulmonary disease (Forced Expiratory Volume in one second [FEV1] < 35%) 15. Respiratory global insufficiency 16. Implantable Cardioverter Defibrillator (ICD) implantation

Design outcomes

Primary

MeasureTime frame
In accordance with the two training methods there are different training recommendations.

Secondary

MeasureTime frame
Training efficiency is enhanced by the intensity regulation based on metabolic parameters.

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026